Drug Eluting Stent Global Market Report 2024 – Market Size, Trends, And Global Forecast 2024-2033

The Business Research Company has updated its global market reports with latest data for 2024 and projections up to 2033

LONDON, GREATER LONDON , UK, June 19, 2024 /EINPresswire.com/ -- The global drug eluting stent market has experienced robust growth in recent years. It is projected to increase from $7.05 billion in 2023 to $7.63 billion in 2024, at a compound annual growth rate (CAGR) of 8.2%. This growth in the historic period can be attributed to the need for improved treatment options, clinical evidence, regulatory approval, healthcare economics, and guidelines and recommendations.

The drug eluting stent market is expected to continue its strong growth trajectory, reaching $10.52 billion by 2028 at a CAGR of 8.4%. This forecasted growth can be attributed to an aging population and chronic disease burden, the expansion of indications, healthcare reimbursement policies, global market expansion, and patient-centered care.

Explore comprehensive insights into the global drug eluting stent market with a detailed sample report:
https://www.thebusinessresearchcompany.com/sample_request?id=15557&type=smp

Impact Of Coronary Heart Disease On Drug-Eluting Stent Market
The rising burden of coronary heart disease (CHD) is expected to propel the growth of the drug eluting stent market. CHD occurs when the coronary arteries become narrowed or blocked due to plaque buildup, potentially leading to severe complications such as heart attacks or chest pain. Factors such as sedentary lifestyles, poor diets, aging populations, and heightened awareness are contributing to the increase in coronary heart disease. Drug-eluting stents (DES) effectively open narrowed or blocked coronary arteries and release medication that helps prevent re-narrowing (restenosis) of the artery.

Drug Eluting Stent Market Key Players and Market Trends
Major companies operating in the drug eluting stent market include Johnson & Johnson Services Inc., Abbott, Medtronic plc, Boston Scientific Corporation, Terumo Corporation, InspireMD Inc., B. Braun Melsungen AG, Cook Group Incorporated, Lepu Medical Technology (Beijing) Co. Ltd., Biotronik, Meril Life Sciences Pvt. Ltd., MicroPort Scientific Corporation, Biosensors International Group Ltd., OrbusNeich Medical Company Limited, Alvimedica Medical Technologies, Hexacath, Elixir Medical Corporation, Translumina GmbH, Cardionovum GmbH, QualiMed Innovative Medizinprodukte GmbH, InSitu Technologies Inc., Acrostak AG, SINOMED Innovation Inc., and Svelte Medical Systems Inc.

Innovation In Advanced Drug-Eluting Coronary Stents
Companies in the drug eluting stent market are focusing on developing innovative delivery systems, such as the dual-layer balloon, to improve patient outcomes and advance interventional cardiology. A dual-layer balloon in a drug-eluting stent system enhances precision in drug delivery and stent deployment by providing better control and uniform drug application to the arterial wall.

Drug Eluting Stent Market Segments:
• By Product: Polymer-Based, Polymer-Free
• By Drug: Sirolimus, Paclitaxel, Zotarolimus, Everolimus, Biolimus, Other Drugs
• By Scaffold: Cobalt-Chromium, Platinum-Chromium, Nitinol, Biodegradable, Other Scaffolds
• By Application: Coronary Diseases, Peripheral Vascular Diseases
• By End-User: Hospitals, Specialty Clinics

Geographical Insights: North America Leading the Market
North America was the largest region in the drug eluting stent market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The report covers regions including Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, providing detailed insights into regional dynamics, market trends, and growth opportunities.

Access the complete report for an in-depth analysis of the global drug eluting stent market:
https://www.thebusinessresearchcompany.com/report/drug-eluting-stent-global-market-report

Drug Eluting Stent Global Market Report 2024 from TBRC covers the following information:
• Market size data for the forecast period: Historical and Future
• Market analysis by region: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
• Market analysis by countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Trends, opportunities, strategies and so much more.
The Drug Eluting Stent Global Market Report 2024 by The Business Research Company is the most comprehensive report that provides insights on drug eluting stent market size, drug eluting stent market drivers and trends, drug eluting stent market major players, competitors' revenues, market positioning, and market growth across geographies. The drug eluting stent market report helps you gain in-depth insights on opportunities and strategies. Companies can leverage the data in the report and tap into segments with the highest growth potential.

Browse Through More Similar Reports By The Business Research Company:
Drug Eluting Balloons Catheters Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/drug-eluting-balloons-catheters-global-market-report

Bioabsorbable Stents Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/bioabsorbable-stents-global-market-report

Intracranial Stents Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/intracranial-stents-global-market-report

About The Business Research Company
The Business Research Company has published over 27 industries, spanning over 8000+ markets and 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Global Market Model – Market Intelligence Database
The Global Market Model, The Business Research Company’s flagship product, is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets that help its users assess supply-demand gaps.

Contact Information
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
info@tbrc.info
Visit us on social media:
Facebook
Twitter
LinkedIn

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.